Repligen Stock (NASDAQ: RGEN) stock price, news, charts, stock research, profile.
Open | $125.50 |
Close | $129.58 |
Volume / Avg. | 497.81K / 684.41K |
Day Range | 122.89 - 129.68 |
52 Wk Range | 110.45 - 211.13 |
Market Cap | $7.24B |
P/E Ratio | 458.56 |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 50 |
Short Interest | 8.82% |
Days to Cover | 3.85 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Repligen (NASDAQ:RGEN) through any online brokerage.
Other companies in Repligen’s space includes: Medpace Hldgs (NASDAQ:MEDP), Agilent Technologies (NYSE:A), 10x Genomics (NASDAQ:TXG), BioLife Solns (NASDAQ:BLFS) and Waters (NYSE:WAT).
There is no analysis for Repligen.
Repligen has a consensus price target of $206.09.
The stock price for Repligen (NASDAQ: RGEN) is $129.58 last updated Today at July 22, 2024 at 4:00 PM EDT.
There are no upcoming dividends for Repligen.
Repligen’s Q2 earnings are confirmed for Tuesday, July 30, 2024.
There is no upcoming split for Repligen.
Repligen is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NASDAQ.